BILCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62 INR | -3.65% |
|
+3.04% | -21.55% |
| Sales 2022 | 8.45B 101M | Sales 2023 | 9.82B 118M | Capitalization | 1.02B 12.27M |
|---|---|---|---|---|---|
| Net income 2022 | -126M -1.51M | Net income 2023 | 150M 1.8M | EV / Sales 2022 | 0.96 x |
| Net Debt 2022 | 6.5B 77.96M | Net Debt 2023 | 6.08B 72.91M | EV / Sales 2023 | 0.72 x |
| P/E ratio 2022 |
-13.1
x | P/E ratio 2023 |
6.8
x | Employees | 70 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.72% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.65% | ||
| 1 week | +3.04% | ||
| Current month | +10.50% | ||
| 1 month | +6.57% | ||
| 3 months | -22.90% | ||
| 6 months | -14.07% | ||
| Current year | -21.55% |
1 week
60.02
65.00
1 month
54.4066.60
Current year
54.0195.40
1 year
42.4795.40
3 years
31.10119.25
5 years
12.30119.25
10 years
12.30119.25
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 87-06-30 | |
Deepa Mathur
DFI | Director of Finance/CFO | - | 23-09-05 |
| Chairman | 32 | 22-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 87-06-30 | |
Rajesh S. Devene
BRD | Director/Board Member | 54 | 19-04-21 |
| Director/Board Member | 64 | 19-06-14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 62 | -3.65% | 43,056 |
| 24-04-25 | 64.35 | +3.31% | 30,123 |
| 24-04-24 | 62.29 | +1.57% | 13,723 |
| 24-04-23 | 61.33 | -0.95% | 9,421 |
| 24-04-22 | 61.92 | +2.91% | 18,774 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:29 am EDT
More quotes
Bilcare Limited is an India-based company, which provides packaging material solutions to the pharmaceutical industry, to improve patient healthcare outcomes. The Company is involved in the business of pharmaceutical packaging, global clinical services, research and development (R&D) services and anti-counterfeit technology (nCid). The Company offers a range of specialty polymer films and aluminum foils mainly used for packaging of solid-dosage pharmaceutical products. It handles domestic and global manufacturing of investigational medicinal products (IMPs) and placebos, primary and secondary packaging with various blinding techniques, interactive Web response systems (IWRS), storage at variable temperatures along with distribution on global depots/sites, which have approximately 30+ depots spread worldwide. The Company's manufacturing plant is located in Pune, India. The Company has operations in India, Singapore, Germany, and the United States.
Calendar
2024-05-29
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -21.55% | 17.5M | |
| +21.35% | 21.97B | |
| +8.34% | 17.64B | |
| -12.49% | 9.62B | |
| +19.15% | 9.29B | |
| +3.78% | 5.01B | |
| -13.09% | 4.62B | |
| +12.87% | 2.98B | |
| -5.60% | 2.96B | |
| +13.27% | 2.78B |
- Stock Market
- Equities
- BILCARE6 Stock
